The Risk of Intracranial Hemorrhage after Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke in Prasat Neurological Institute
พ.ศ. 2561
Factors Associated with Symptomatic Intracerebral Hemorrhage after Thrombolytic Therapy in Acute Ischemic Stroke
พ.ศ. 2558
A Study of Effectiveness of Low Dose versus Standard Dose Intravenous Recombinant Tissue-type Plasminogen Activator in Acute Ischemic Stroke in Phramongkutklao Hospital
Trend in recombinant tissue plasminogen activator (rtPA) use for ischemic stroke in Thailand: Geographic inequality, cost of treatment and impact on 30-day case fatality rate
Evaluation of the efficacy of recombinant tissue plasminogen activators in improving clinical status of acute ischemic stroke: A randomized clinical trial in Iran